Stock CCEL CRYO-CELL INTERNATIONAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Cryo-Cell International, Inc.

Equities

CCEL

US2288951088

Delayed Nyse
Other stock markets
 11:26:41 2024-05-24 am EDT 		5-day change 1st Jan Change
9.4 USD +2.84% Intraday chart for Cryo-Cell International, Inc. +4.44% +63.48%
Apr. 15 Cryo-Cell International, Inc. Reports Earnings Results for the First Quarter Ended February 29, 2024 CI
Mar. 25 Cryo-Cell International to Spin Off Celle Unit, Explore Strategic Alternatives; Shares Jump MT

Summary

  • On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.

Strengths

  • For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.

Weaknesses

  • Low profitability weakens the company.
  • The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 304.67 times its estimated earnings per share for the ongoing year.
  • For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
  • The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.

Ratings chart - Surperformance

Sector: Healthcare Facilities & Services

1st Jan change Capi. Investor Rating ESG Refinitiv
CRYO-CELL INTERNATIONAL, INC. Stock Cryo-Cell International, Inc.
+63.48% 74.07M -
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+17.73% 82.59B
C+
CVS HEALTH CORPORATION Stock CVS Health Corporation
-28.96% 69.86B
B-
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
0.00% 26.5B
C+
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+3.06% 17.29B
A-
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-13.43% 16.61B
B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+2.00% 15.56B
A-
NATERA, INC. Stock Natera, Inc.
+75.22% 13.2B
C-
REDE D'OR SÃO LUIZ S.A. Stock Rede D'Or São Luiz S.A.
+1.67% 12.75B
B-
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+73.98% 12.6B
C+
Investor Rating
Trading Rating
-
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
-

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality
  1. Stock Market
  2. Equities
  3. CCEL Stock
  4. Ratings Cryo-Cell International, Inc.